Abstract
Ultrasound-guided axillary brachial plexus block is increasingly used in preschool-age patients. However, the minimum effective volume of local anaesthetics has not been determined. With ethical committee approval and written informed consent from the guardians of all paediatric patients, we studied 27 consecutive patients aged 3 to 6 years who were scheduled for hand surgery. After general anaesthesia, eligible patients received a set volume of ultrasound-guided axillary brachial plexus block. We determined the volume of 0.2% ropivacaine for consecutive patients from the preceding patient’s outcome. The initial volume was 0.4 ml/kg. The testing interval was set at 0.05 ml/kg, and the lowest volume was 0.1 ml/kg. The following conditions were defined as a successful block: no heart rate changes, body movement, or ventilatory disorders during the operation; no use of fentanyl in the PACU; and a postoperative sensory block score < 3. The sequences of positive and negative blocks in consecutive patients were recorded. Using probit regression analysis, the 50% effective volume was 0.185 ml/kg (95% CI 0.123–0.234), and the 95% effective volume was 0.280 ml/kg (95% CI 0.232–0.593). EV50 and EV95 values of 0.2% ropivacaine for ultrasound-guided axillary brachial plexus block were 0.185 ml/kg and 0.280 ml/kg, respectively.
Highlights
Axillary brachial plexus block (ABPB) is a common anaesthesia method in upper limb surgery and, compared to other brachial plexus block approaches, presents almost no risk of phrenic nerve block or pneumothorax
With the widespread use of ultrasound technology1–3, nerve blocks are widely used in paediatric surgery and can reduce the amount of opioids required for general anaesthesia or as analgesics after surgery
The minimum effective volume (MEV) of ropivacaine required for ultrasound-guided brachial plexus nerve block has not been determined in children4
Summary
Axillary brachial plexus block (ABPB) is a common anaesthesia method in upper limb surgery and, compared to other brachial plexus block approaches, presents almost no risk of phrenic nerve block or pneumothorax. It uses large amounts of local anaesthetics, increasing the risk of local anaesthetic toxicity. The minimum effective volume (MEV) of ropivacaine required for ultrasound-guided brachial plexus nerve block has not been determined in children. Due to the small volume of anaesthetics used in paediatric patients, we used a single point injection for ABPB We designed this prospective sequential trial to determine the minimum effective volumes (EV50 and EV95) of 0.2% ropivacaine
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have